Bacterial attenuation method and vaccine
CA 2094515 C · Owner: Kramer, Theodore T. · Inventors: Kramer, Theodore T.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed herein are methods for attenuating virulent Gram negative bacteria to produce avirulent bacteria. The methods comprise passaging the wild-type bacteria through phagocytic cells such as macrophages or polymorphonuclear leukocytes or, through lysosomes derived from such cells a sufficient number of times until the bacteria become avirulent to the animal host. The bacteria are preferably from the family Enterobacteracea and most preferably from the genus Salmonellae. The invention further comprises the avirulent bacteria produced by the methods pure cultures of such bacteria, and methods of using the bacteria, preferably in a vaccine for administering to an animal host to induce an …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 31, 1991 and granted September 1, 1998. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 31, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 31, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.